
UTHR Technical Analysis Summary (NASDAQ)
Analyze UTHR on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerUTHR Technical Analysis Summary (NASDAQ)
United Therapeutics Corporation (NASDAQ: UTHR) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.
Technical conditions suggest United Therapeutics Corporation on the NASDAQ is awaiting a decisive move. Overall, United Therapeutics Corporation remains neutral, with indicators showing mixed momentum.
RSI (14): 60.05
Stochastic %K: 77.47
Williams %R: -37.74
Rate of Change (ROC): 7.76
Takeaway:United Therapeutics Corporation shows strong bullish momentum, with buyers firmly in control.
MACD: 4.94
ADX: 29.01
ATR (14): 21.10
CCI (14): 167.09
Takeaway:United Therapeutics Corporation shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:United Therapeutics Corporation trades closer to resistance, supported by stronger momentum within bands.
Takeaway:United Therapeutics Corporation trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:UTHR shows neutral money flow, with no clear directional pressure.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
Overall Recommendation:United Therapeutics Corporation currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.